96 related articles for article (PubMed ID: 7692200)
1. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 variant exons 8-10 in gastric cancer.
Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
[TBL] [Abstract][Full Text] [Related]
3. Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells.
Jang E; Shin MK; Kim H; Lim JY; Lee JE; Park J; Kim J; Kim H; Shin Y; Son HY; Choi YY; Hyung WJ; Noh SH; Suh JS; Sung JY; Huh YM; Cheong JH
Exp Mol Med; 2023 May; 55(5):974-986. PubMed ID: 37121972
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG
Bagheri V; Gholamin M; Mansouri A; Abbaszadegan MR
Med Oncol; 2022 Sep; 39(12):201. PubMed ID: 36175578
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Girda E; Hou J; Nelson D; Finlayson M; de Meritens AB; Chekmareiva M; Leiser A; Song M; Stephenson R; Chan N; Tergas AI; Vattakalam R; Wright JD; Yu H; Martincuks A; Kohut A; Palmer J; Rodriguez-Rodriguez L
Int J Gynecol Cancer; 2022 Jun; 32(8):1032-8. PubMed ID: 35750354
[TBL] [Abstract][Full Text] [Related]
6. Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling.
Xiang R; Song W; Ren J; Wu J; Fu J; Fu T
Stem Cell Res Ther; 2021 Oct; 12(1):563. PubMed ID: 34717747
[TBL] [Abstract][Full Text] [Related]
7. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics.
Chaudhry GE; Akim A; Naveed Zafar M; Safdar N; Sung YY; Muhammad TST
Adv Pharm Bull; 2021 May; 11(3):426-438. PubMed ID: 34513617
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting.
Zhang D; Huang J; Li W; Zhang Z; Zhu M; Feng Y; Zhao Y; Li Y; Lu S; He S
Ann Transl Med; 2020 Nov; 8(21):1442. PubMed ID: 33313187
[TBL] [Abstract][Full Text] [Related]
9. Impact of Truncated
Moreira IB; Pinto F; Gomes C; Campos D; Reis CA
Cells; 2020 Jan; 9(2):. PubMed ID: 31973075
[TBL] [Abstract][Full Text] [Related]
10. High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.
Kagami T; Yamade M; Suzuki T; Uotani T; Tani S; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Baba S; Sugimura H; Miyajima H; Furuta T
Oncotarget; 2018 Oct; 9(79):34876-34888. PubMed ID: 30405881
[TBL] [Abstract][Full Text] [Related]
11. The biology and role of CD44 in cancer progression: therapeutic implications.
Chen C; Zhao S; Karnad A; Freeman JW
J Hematol Oncol; 2018 May; 11(1):64. PubMed ID: 29747682
[TBL] [Abstract][Full Text] [Related]
12. CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling.
Lourenço BN; Springer NL; Ferreira D; Oliveira C; Granja PL; Fischbach C
Integr Biol (Camb); 2018 Mar; 10(3):145-158. PubMed ID: 29450424
[TBL] [Abstract][Full Text] [Related]
13. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.
Eguchi T; Sogawa C; Okusha Y; Uchibe K; Iinuma R; Ono K; Nakano K; Murakami J; Itoh M; Arai K; Fujiwara T; Namba Y; Murata Y; Ohyama K; Shimomura M; Okamura H; Takigawa M; Nakatsura T; Kozaki KI; Okamoto K; Calderwood SK
PLoS One; 2018; 13(2):e0191109. PubMed ID: 29415026
[TBL] [Abstract][Full Text] [Related]
14. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.
Flanagan DJ; Vincan E; Phesse TJ
Br J Pharmacol; 2017 Dec; 174(24):4666-4683. PubMed ID: 28568899
[TBL] [Abstract][Full Text] [Related]
15. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.
Li W; Jia H; Wang J; Guan H; Li Y; Zhang D; Tang Y; Wang TD; Lu S
Oncotarget; 2017 May; 8(18):30063-30076. PubMed ID: 28415792
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
17. Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction.
Wang Y; Liu Y; Xiao B
Oncol Lett; 2015 Nov; 10(5):2962-2966. PubMed ID: 26722272
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer stem cells: evidence, potential markers, and clinical implications.
Brungs D; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
J Gastroenterol; 2016 Apr; 51(4):313-26. PubMed ID: 26428661
[TBL] [Abstract][Full Text] [Related]
19. CD44 family proteins in gastric cancer: a meta-analysis and narrative review.
Wu Y; Li Z; Zhang C; Yu K; Teng Z; Zheng G; Wang S; Liu Y; Cui L; Yu X
Int J Clin Exp Med; 2015; 8(3):3595-606. PubMed ID: 26064255
[TBL] [Abstract][Full Text] [Related]
20. Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.
Wang W; Dong LP; Zhang N; Zhao CH
Int J Clin Exp Med; 2014; 7(12):5059-66. PubMed ID: 25664005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
